HEMATOLOGIC MALIGNANCY

This study tested whether a smartphone app could help cancer patients remember to take their oral medications better than a traditional paper diary. It involved 124 adults with various cancers who were prescribed pill-based treatments. Researchers compared the two methods to see …

This study monitored the safety and effectiveness of the drug Besponsa in Korean patients with a hard-to-treat form of blood cancer (B-cell ALL). It was a required safety check after the drug was approved for sale, involving 108 patients who received the drug as part of their nor…

This study tested if paying for blood transfusions would help people with advanced blood cancers choose hospice care earlier. Patients often delay hospice because they need transfusions, which hospice usually doesn't cover. The research provided free transfusions to see if this h…

This small study tested whether giving blood transfusions at home is a practical and acceptable option for patients with advanced blood cancers who are in hospice care. It involved 10 patients with a life expectancy of six months or less, along with their caregivers. The main goa…

This study tested whether a 12-week exercise program could help people recover after a stem cell transplant for blood cancer. Sixteen patients and their caregivers followed a program of high-intensity interval training and strength exercises. Researchers measured changes in physi…

This study aimed to learn about the community of microbes (like bacteria, fungi, and viruses) living in the mouths and noses of children with cancer. Researchers collected samples from 62 children with leukemia or those receiving a bone marrow transplant at three different times …

This study looked at whether having a congenital heart defect affects long-term health and quality of life for children who have survived blood cancers like leukemia. Researchers followed 800 survivors to compare those with heart defects to those without, tracking health outcomes…

This study aimed to understand how well the Pfizer COVID-19 vaccine works in adults with weakened immune systems compared to healthy adults. Researchers measured antibody levels in the blood and nose of 196 participants, including people with conditions like cancer, HIV, and orga…